These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12658209)

  • 1. Hyperoxia elicits myocardial protection through a nuclear factor kappaB-dependent mechanism in the rat heart.
    Tähepõld P; Vaage J; Starkopf J; Valen G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):650-60. PubMed ID: 12658209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity.
    Kaljusto ML; Stensløkken KO; Mori T; Panchenko A; Frantzen ML; Valen G; Vaage J
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):355-63. PubMed ID: 18221880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart.
    Li C; Browder W; Kao RL
    Am J Physiol; 1999 Feb; 276(2):H543-52. PubMed ID: 9950856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants attenuate reperfusion injury after global brain ischemia through inhibiting nuclear factor-kappa B activity in rats.
    Shen WH; Zhang CY; Zhang GY
    Acta Pharmacol Sin; 2003 Nov; 24(11):1125-30. PubMed ID: 14627497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia and reperfusion-induced arrhythmias: role of hyperoxic preconditioning.
    Pourkhalili K; Hajizadeh S; Tiraihi T; Akbari Z; Esmailidehaj M; Bigdeli MR; Khoshbaten A
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):635-42. PubMed ID: 19455051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection by breathing hyperoxic gas-relation to oxygen concentration and exposure time in rats and mice.
    Tähepõld P; Ruusalepp A; Li G; Vaage J; Starkopf J; Valen G
    Eur J Cardiothorac Surg; 2002 Jun; 21(6):987-94. PubMed ID: 12048075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion.
    Zhong C; Zhou Y; Liu H
    Anesthesiology; 2004 Mar; 100(3):540-6. PubMed ID: 15108966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NF kappa B activation by pyrrolidine dithiocarbamate prevents in vivo hypoxia/reoxygenation-mediated myocardial angiogenesis.
    Sasaki H; Zhu L; Fukuda S; Maulik N
    Int J Tissue React; 2000; 22(4):93-100. PubMed ID: 11199341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM; Jia Z; Zhou ZQ; Xu JG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-kappaB and reduces myocardial infarct size in rats.
    Meili-Butz S; Niermann T; Fasler-Kan E; Barbosa V; Butz N; John D; Brink M; Buser PT; Zaugg CE
    Eur J Pharmacol; 2008 May; 586(1-3):251-8. PubMed ID: 18405893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart.
    Tähep ld P; Valen G; Starkopf J; Kairane C; Zilmer M; Vaage J
    Life Sci; 2001 Feb; 68(14):1629-40. PubMed ID: 11263675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pyrrolidine dithiocarbamate on hepatic vascular stress gene expression during ischemia and reperfusion.
    Lee CH; Kim SH; Lee SM
    Eur J Pharmacol; 2008 Oct; 595(1-3):100-7. PubMed ID: 18722366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of a nuclear factor-kappaB inhibitor on ischemia-reperfusion injury in a rat epigastric flap model.
    Wu X; Yu M; Li A
    J Reconstr Microsurg; 2008 Jul; 24(5):351-9. PubMed ID: 18597218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin (rhEPO) preconditioning on nuclear factor-kappa B (NF-kB) activation & proinflammatory cytokines induced by myocardial ischaemia-reperfusion.
    Liu X; Shen J; Jin Y; Duan M; Xu J
    Indian J Med Res; 2006 Sep; 124(3):343-54. PubMed ID: 17085838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats.
    La Rosa G; Cardali S; Genovese T; Conti A; Di Paola R; La Torre D; Cacciola F; Cuzzocrea S
    J Neurosurg Spine; 2004 Oct; 1(3):311-21. PubMed ID: 15478370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nuclear factor-kappaB in the effect of angiotensin II in the paraventricular nucleus in protecting the gastric mucosa from ischemia-reperfusion injury in rats.
    Zhang YM; Wei EQ; Hu X; Qiao WL; Shi Y; Xu M; Zhang JF
    J Gastroenterol; 2008; 43(9):687-98. PubMed ID: 18807130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
    Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
    Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury.
    Altavilla D; Deodato B; Campo GM; Arlotta M; Miano M; Squadrito G; Saitta A; Cucinotta D; Ceccarelli S; Ferlito M; Tringali M; Minutoli L; Caputi AP; Squadrito F
    Cardiovasc Res; 2000 Aug; 47(3):515-28. PubMed ID: 10963724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.